Funding announced in this week’s federal budget moves Australia closer to eliminating HIV.
Rigor acadêmico, estilo jornalístico
Todos os artigos de HIV infection
Exibindo todos artigos
Until then we need to get effective, accessible treatment for all who need it, while deploying the many prevention tools at our disposal.
Three new HIV vaccine concepts which rely on high-tech designer proteins are being trialled to see if they can stop the virus.
A public inquiry into the infected blood scandal will identify where fault lies, but what reparations are the courts able to provide?
In Russia, social networks have given a new life to the conspiracy theory that HIV-AIDS is a global hoax.
For the next five years South Africa will be leading one of the latest large-scale trials for a vaccine for HIV.
Principais colaboradores
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Medical Scientist at the National Institute for Communicable Diseases; Research Associate at CAPRISA; Research Professor in the School of Pathology, University of the Witwatersrand
-
Research Professor and DST/NRF SARChI Chair of Virus-Host Dynamics, National Institute for Communicable Diseases, CAPRISA Research Associate, University of the Witwatersrand
-
Junior research fellow, Russian National Research University The Higher School of Economics
-
Researcher, Russian National Research University The Higher School of Economics
-
Lecturer in Healthcare Law, University of Southampton
-
Associate Professor/Senior Research Fellow, International Centre for Health Economics, Management and Policy, Russian National Research University The Higher School of Economics
-
Senior lecturer, public health ethics, School of Population Health, UNSW Sydney
